Member Info for MU345

Shorting a company providing jobs for over 50,000 currently in some financial distress.

Hope you sleep well at night.

Warren Buffet. Who is a contrarian investor.

If the company didn’t have a going concern we’d be paying 600p+.

The risk is the company is unable to ride the storm. I very much doubt that’s a possibility. Other sections of the business remain resilient, whilst the cost of losing Rolls to the UK government is far too great to see it fall short due to unforeseen circumstances imo.

I’ll continue to buy in tranches during these times of low sentiment and will be holding for the long term. So I’m happy whichever way the SP goes at the moment. Great opportunity if you can stomach some short term volatility.

I wonder if the bloke who’s just bought £159,000 worth is listening to novice investors constant drivel...

Must be sad times for the derampers who have watched this go up 60% in the last few days...

It’ll be even worse for them over the next few months..

Obviously great for LTH’s though.

Wouldn’t worry about not hitting £1 today. I’m not slicing until £2.

Far too much news and development in the pipeline to even consider selling even a bean now.

Really is just the start. MHRA could drop any day and that’ll see us heading towards £2 alone.

“Also MU345, there won't be annual demand for this product. Be lucky if they get 2 years out of it“

Can you say that comprehensively? Knowing the importance of the antibody test alongside a successful vaccine? There’s also the unfortunate circumstance there isn’t a successful vaccine.

Sorry, but your suggestions really don’t stand up.

Even at 2 years full capacity. We are looking substantially above current mcap..

2,000,000 tests per week at £1/£2/£3+ average margins provides yearly profits upwards of £150,000,000.

What’s so difficult to grasp?

What you have at the moment is lots of firms with tests but not the manufacturing capacity to be able to produce them to the required scale. Supply/ Demand.

Exactly. £0.75 is now likely worst case scenario for predicting profits and even then it significantly outweighs the current mcap.

2,000,000+ tests per week once facilities are complete. Which if at an average profit of £1.50 per test. (RTC 0.75 / Mologic antibody £1.80 / ( global RTC / antigen potentially
More lucrative ).

Provides Yearly profit at full capacity of £144,000,000.

Not including food intolerance and CD4 profits. Whilst capacity could be extended beyond this if there’s enough demand for the 5 top tier covid tests in a global pandemic.

Some have a target of £5 and it’s simple to see why. The other sections of the business are forecast to grow exponentially in the coming years also.

Investor presentation 2,000,000 + per week

This morning? Or this afternoon?

Still invested.. been buying all day. Or at least trying too!

Share price drives sentiment with some unfortunately.

Tree shake was coming. Though I doubt they can hold it down long.

A “fairly determined rattle” is probably the best they can pull off. I expect there’ll be many waiting for a dip to buy into.

Even more so as the value here starts to be recognised.

Looks like the MM’s want some shares take it up quickly and give it a little shake. Classic.

I wonder whether we’ll be closer to 90p or 100p at close...

Expecting the trend to continue with another strong day especially with notification of the increased capacity to 500,000.

Should be knocking on the door of £1 shortly, RNS or not.

Hope that FOMO bus is a double decker!

Wouldn’t want to be out of this for a minute.

Agreed, this morning has been an absolute gift.

Director bought at 0.225.

I’m enjoying accumulating at these prices that’s for sure.

No DDDD or VAL are the hottest shares with biggest potential in Sept?

You are expecting upwards of 500% gains in DDDD and VAL?!? Well.. good luck with that.